An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists

por Chen, Xia, de Haas, Sanne, de Kam, Marieke, van Gerven, Joop
Publicado 2012

Sensitivity of cognitive function tests to acute hypoxia in healthy subjects: a systematic literature review

por Post, Titiaan E., Heijn, Laurens G., Jordan, Jens, van Gerven, Joop M. A.
Publicado 2023

The Role of the Noradrenergic System in the Exploration–Exploitation Trade-Off: A Psychopharmacological Study

por Jepma, Marieke, te Beek, Erik T., Wagenmakers, Eric-Jan, van Gerven, Joop M.A., Nieuwenhuis, Sander
Publicado 2010

Stability analysis of clustering of Norris’ visual analogue scale: Applying the consensus clustering approach

por Guan, Zheng, Chen, X. Gregory, Hay, Justin, van Gerven, Joop, Burggraaf, Jacobus, de Kam, Marieke
Publicado 2021

PK/PD modeling of 5‐hydroxytryptophan (5‐HTP) challenge test with cortisol measurement in serum and saliva

por Guan, Zheng, Jacobs, Gabriel, van Pelt, Hans, Van Gerven, Joop M.A., Burggraaf, Jacobus, Zhao, Wei
Publicado 2020

Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)

por Lansbergen, Marieke M., Dumont, Glenn J. H., van Gerven, Joop M. A., Buitelaar, Jan K., Verkes, Robbert-Jan
Publicado 2010

Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers

por Dijkstra, Francis, O’Donnell, Patricio, Klaassen, Erica, Buhl, Derek, Asgharnejad, Mahnaz, Rosen, Laura, Zuiker, Rob, van Gerven, Joop, Jacobs, Gabriël
Publicado 2022

Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool

por Kwee, Caroline MB, van Gerven, Joop MA, Bongaerts, Fleur LP, Cath, Danielle C, Jacobs, Gabriël, Baas, Johanna MP, Groenink, Lucianne
Publicado 2022

Diminished Posterior Precuneus Connectivity with the Default Mode Network Differentiates Normal Aging from Alzheimer's Disease

por Klaassens, Bernadet L., van Gerven, Joop M. A., van der Grond, Jeroen, de Vos, Frank, Möller, Christiane, Rombouts, Serge A. R. B.
Publicado 2017

EEG machine learning for accurate detection of cholinergic intervention and Alzheimer’s disease

por Simpraga, Sonja, Alvarez-Jimenez, Ricardo, Mansvelder, Huibert D., van Gerven, Joop M. A., Groeneveld, Geert Jan, Poil, Simon-Shlomo, Linkenkaer-Hansen, Klaus
Publicado 2017

Involvement of the endocannabinoid system in reward processing in the human brain

por van Hell, Hendrika H., Jager, Gerry, Bossong, Matthijs G., Brouwer, Annelies, Jansma, J. Martijn, Zuurman, Lineke, van Gerven, Joop, Kahn, René S., Ramsey, Nick F.
Publicado 2011

Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: (18)F-Fallypride Positron Emission Tomography Study

por Kuepper, Rebecca, Ceccarini, Jenny, Lataster, Johan, van Os, Jim, van Kroonenburgh, Marinus, van Gerven, Joop M. A., Marcelis, Machteld, Van Laere, Koen, Henquet, Cécile
Publicado 2013

Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation

por Klaassens, Bernadet L., Rombouts, Serge A.R.B., Winkler, Anderson M., van Gorsel, Helene C., van der Grond, Jeroen, van Gerven, Joop M.A.
Publicado 2016

COVID‐19 vaccines: the importance of transparency and fact‐based education

por Cohen, Adam F., van Gerven, Joop, Burgos, Juan Garcia, de Boer, Anthonius, Foucher, Ron A. M., Flore, H., Teitelbaum, Zvi, van Eden, Willem, Webb, Andrew, Cremers, Serge
Publicado 2020

Biperiden Challenge Model in Healthy Elderly as Proof‐of‐Pharmacology Tool: A Randomized, Placebo‐Controlled Trial

por Bakker, Charlotte, van Esdonk, Michiel J., Stuurman, Rik (F). E., Borghans, Laura G.J.M., de Kam, Marieke L., van Gerven, Joop M.A., Groeneveld, Geert Jan
Publicado 2021

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study

por Morrison, Randall L., Fedgchin, Maggie, Singh, Jaskaran, Van Gerven, Joop, Zuiker, Rob, Lim, Kyoung Soo, van der Ark, Peter, Wajs, Ewa, Xi, Liwen, Zannikos, Peter, Drevets, Wayne C.
Publicado 2018

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder

por Recourt, Kasper, de Boer, Peter, Zuiker, Rob, Luthringer, Remy, Kent, Justine, van der Ark, Peter, Van Hove, Ilse, van Gerven, Joop, Jacobs, Gabriel, van Nueten, Luc, Drevets, Wayne
Publicado 2019

Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder

por Recourt, Kasper, de Boer, Peter, Zuiker, Rob, Luthringer, Remy, Kent, Justine, van der Ark, Peter, Van Hove, Ilse, van Gerven, Joop, Jacobs, Gabriel, van Nueten, Luc, Drevets, Wayne
Publicado 2019

Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

por Recourt, Kasper, de Boer, Peter, van der Ark, Peter, Benes, Heike, van Gerven, Joop M. A., Ceusters, Marc, van Nueten, Luc, Drevets, Wayne C., Bhatacharya, Anindya, Browning, Michael, Jacobs, Gabriel E.
Publicado 2023

Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI

por Leijenaar, Jolien F., Groeneveld, Geert Jan, Klaassen, Erica S., Leeuwis, Anna E., Scheltens, Philip, Weinstein, Henry C., van Gerven, Joop M. A., Barkhof, Frederik, van der Flier, Wiesje M., Prins, Niels D.
Publicado 2020